跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Betnovate - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Betnovate
Approved
STANDARD
Betnovate
Glaxo Operations UK Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9bd6eea39150a043
Company
Glaxo Operations UK Limited
Type
Standard
Approval Details
Approval Id
9bd6eea39150a043
Drug Approval Philippines Name
Betnovate
Product Name
Betnovate
Registration Number
DR-4113
Brand Name
Betnovate
Generic Name
Betamethasone (As Valerate)
Dosage Form
Ointment
Dosage Strength
1mg/g (0.1%)
Manufacturer
Glaxo Operations UK Limited
Importer
GlaxoSmithKline Philippines, Inc.
Distributor
GlaxoSmithKline Philippines, Inc.
Company Detail Path
/organization/glaxo-operations-uk-limited
Issuance Date
17 March 2023
Expiry Date
30 April 2028
Pharmacologic Category
Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9bd6eea39150a043
Type
Standard
Back to Philippines FDA Approvals